Phase II Trial of Bevacizumab in Persistent or Recurrent Epithelial Ovarian Cancer or Primary Peritoneal Cancer: A Gynecologic Oncology Group StudyRobert A. Burger, Joel I. Sorosky|Journal of Clinical Oncology|2007Cited by 880
American Society of Clinical Oncology Position Statement on Obesity and CancerJennifer A. Ligibel, Clifford A. Hudis, Kerry S. Courneya et al.|Journal of Clinical Oncology|2014Cited by 524